A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or diseaseVictoria K. Baxter(Texas Biomedical Research Institute), Alex Rubinsteyn(University of North Carolina at Chapel Hill)bioRxiv (Cold Spring Harbor Laboratory)February 24, 202210.1101/2022.02.22.481499Cited by 1SaveCiteExport RISWatch citationsRelated PapersAdjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus|Research Square|2023|0